Guía de Práctica Clínica sobre Lupus Eritematoso Sistémico

624 Mazzucconi MG, Fazi P, Bernasconi S, De Rossi G, Leone G, Gugliotta L et al. Therapy
with high-dose dexamethasone (HD-DXM) in previously untreated patients affected by
idiopathic thrombocytopenic purpura: a GIMEMA experience. Blood 2007; 109: 1401–
1407.
625 Praituan W, Rojnuckarin P. Faster platelet recovery by high-dose dexamethasone
compared with standard-dose prednisolone in adult immune thrombocytopenia: a
prospective randomized trial. J Thromb Haemost 2009; 7: 1036–1038.
626 Zaja F, Baccarani M, Mazza P, Bocchia M, Gugliotta L, Zaccaria A et al. Dexamethasone
plus rituximab yields higher sustained response rates than dexamethasone monotherapy in
adults with primary immune thrombocytopenia. Blood 2010; 115: 2755–2762.
627 Gómez-Almaguer D, Tarín-Arzaga L, Moreno-Jaime B, Jaime-Pérez JC, Ceballos-López
AA, Ruiz-Argüelles GJ et al. High response rate to low-dose rituximab plus high-dose
dexamethasone as frontline therapy in adult patients with primary immune
thrombocytopenia. Eur J Haematol 2013; 90: 494–500.
628 Gudbrandsdottir S, Birgens HS, Frederiksen H, Jensen BA, Jensen MK, Kjeldsen L et al.
Rituximab and dexamethasone vs dexamethasone monotherapy in newly diagnosed
patients with primary immune thrombocytopenia. Blood 2013; 121: 1976–1981.
629 Zhao H, Li S, Yang R. Thrombocytopenia in patients with systemic lupus erythematosus:
significant in the clinical implication and prognosis. Platelets 2010; 21: 380–385.
630 Ziakas PD, Giannouli S, Zintzaras E, Tzioufas a G, Voulgarelis M. Lupus
thrombocytopenia: clinical implications and prognostic significance. Ann Rheum Dis 2005;
64: 1366–1369.
631 Maroun MC, Ososki R, Andersen J, Vasey FB, Dhar JP. Eltrombopag as steroid sparing
therapy for immune thrombocytopenic purpura (ITP) in systemic lupus erythemathosus
(SLE), report of three cases. Arthritis Rheum 2011; 63: 746–750.
632 Magnano L, Enríquez H, Esteve J, Cervera R, Espinosa G. Effectiveness of
Thrombopoietin-receptor Agonists in the Treatment of Refractory Immune
Thrombocytopenia Associated to Systemic Lupus Erythematosus The Journal of
Rheumatology is a monthly international serial edited by Earl D. J Rheumatol 2014; 41: 9–
11.
633 Scheinberg P, Singulane CC, Barbosa LSG, Scheinberg M. Successful platelet count
recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist
eltrombopag. Clin Rheumatol 2014; 33: 1347–1349.
634 Alkaabi JK, Alkindi S, Riyami N Al, Zia F, Balla LM a, Balla SM. Successful treatment of
severe thrombocytopenia with romiplostim in a pregnant patient with systemic lupus
erythematosus. Lupus 2012; 21: 1571–1574.
635 Maroun M, Ososki R, Andersen J, Vasey F, Dhar J. Eltrombopag as steroid sparing
therapy for immune thrombocytopenic purpura (ITP) in systemic lupus erythemathosus
(SLE), report of three cases. 2011.
482 GUÍAS DE PRÁCTICA CLÍNICA EN EL SNS